HAQUE PROMOD 4
4 · Health Catalyst, Inc. · Filed Jul 29, 2019
Insider Transaction Report
Form 4
HAQUE PROMOD
Director10% Owner
Transactions
- Conversion
Series F Convertible Preferred Stock
2019-07-29−35,919→ 0 total(indirect: By Partnership)→ Common Stock (35,919 underlying) - Conversion
Common Stock
2019-07-29+2,952,091→ 2,952,091 total(indirect: By Partnership) - Conversion
Series B Convertible Preferred Stock
2019-07-29−1,442,727→ 0 total(indirect: By Partnership)→ Common Stock (1,442,727 underlying) - Conversion
Series E Convertible Preferred Stock
2019-07-29−424,568→ 0 total(indirect: By Partnership)→ Common Stock (424,568 underlying) - Conversion
Common Stock
2019-07-29+2,952,090→ 2,952,090 total(indirect: By Partnership) - Conversion
Series C Convertible Preferred Stock
2019-07-29−577,045→ 0 total(indirect: By Partnership)→ Common Stock (577,045 underlying) - Conversion
Series D Convertible Preferred Stock
2019-07-29−471,832→ 0 total(indirect: By Partnership)→ Common Stock (471,832 underlying) - Conversion
Series E Convertible Preferred Stock
2019-07-29−424,568→ 0 total(indirect: By Partnership)→ Common Stock (424,568 underlying) - Conversion
Series B Convertible Preferred Stock
2019-07-29−1,442,727→ 0 total(indirect: By Partnership)→ Common Stock (1,442,727 underlying) - Conversion
Series C Convertible Preferred Stock
2019-07-29−577,045→ 0 total(indirect: By Partnership)→ Common Stock (577,045 underlying) - Conversion
Series F Convertible Preferred Stock
2019-07-29−35,919→ 0 total(indirect: By Partnership)→ Common Stock (35,919 underlying) - Conversion
Series D Convertible Preferred Stock
2019-07-29−471,831→ 0 total(indirect: By Partnership)→ Common Stock (471,831 underlying)
Footnotes (7)
- [F1]The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F2]The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F3]The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F4]The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F5]The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F6]The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.
- [F7]The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.